Clinical Trial Update: Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temozolomide in combination with bevacizumab in elderly patients (70 years and older) with supratentorial glioblastoma and impaired f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• Temodar (Temozolomide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Glioblastoma Multiforme, Primary Brain Tumor | Phase 2 | Status: COMPLETED